Lightweight, head-mounted microscope unveils brain oxygenation in freely moving mice

by TranSpreadPhotoacoustic fiberscope for cerebral imaging in the freely moving-state. Credit:Light: Science & Applications(2024). DOI: 10.1038/s41377-023-01348-3The brain consumes app

Updated on: April 06,2024

Lightweight, head-mounted microscope unveils brain oxygenation in freely moving mice

by TranSpreadPhotoacoustic fiberscope for cerebral imaging in the freely moving-state. Credit:Light: Science & Applications(2024). DOI: 10.1038/s41377-023-01348-3The brain consumes app

Updated on:April 06,2024

Alzheimer's trial screening data links high amyloid levels with early stage disease

by National Institutes of HealthPET scan of a human brain with Alzheimer's disease. Credit: public domainThe first published data from the Anti-Amyloid Treatment in Asymptomatic Alzheimer&#39

Updated on: April 20,2024

Alzheimer's trial screening data links high amyloid levels with early stage disease

by National Institutes of HealthPET scan of a human brain with Alzheimer's disease. Credit: public domainThe first published data from the Anti-Amyloid Treatment in Asymptomatic Alzheimer&#39

Updated on:April 20,2024

Alzheimer's gene-mapping project proposed in New York state

A proposed project to map the genes of 1 million people in New York living with or at risk for Alzheimer disease was announced Friday by Gov. Andrew Cuomo.He said the five years of data collected by t

Updated on: April 20,2024

Alzheimer's gene-mapping project proposed in New York state

A proposed project to map the genes of 1 million people in New York living with or at risk for Alzheimer disease was announced Friday by Gov. Andrew Cuomo.He said the five years of data collected by t

Updated on:April 20,2024

Facebook app offers opportunity to help unpaid Alzheimer's caregivers via friendsourcing

by Indiana UniversityDavid Wilkerson, an assistant professor in the IU School of Social Work and a member of the Facebook app research team. Credit: IU School of Social WorkResearchers at IUPUI h

Updated on: March 30,2024

Facebook app offers opportunity to help unpaid Alzheimer's caregivers via friendsourcing

by Indiana UniversityDavid Wilkerson, an assistant professor in the IU School of Social Work and a member of the Facebook app research team. Credit: IU School of Social WorkResearchers at IUPUI h

Updated on:March 30,2024

Analyzing internal world models of humans, animals and AI

byUniversity of FreiburgCredit: Pixabay/CC0 Public DomainA team of scientists led by Prof. Dr. Ilka Diester, Professor of Optophysiology and spokesperson of the BrainLinks-BrainTools research ce

Updated on: July 31,2024

Analyzing internal world models of humans, animals and AI

byUniversity of FreiburgCredit: Pixabay/CC0 Public DomainA team of scientists led by Prof. Dr. Ilka Diester, Professor of Optophysiology and spokesperson of the BrainLinks-BrainTools research ce

Updated on:July 31,2024

How much does dementia risk increase after traumatic brain injury?

by Public Library of ScienceThe WHO has predicted that TBI will become a leading cause of death and long-term illness during the next ten years. Already one per cent of the population in the United St

Updated on: May 13,2024

How much does dementia risk increase after traumatic brain injury?

by Public Library of ScienceThe WHO has predicted that TBI will become a leading cause of death and long-term illness during the next ten years. Already one per cent of the population in the United St

Updated on:May 13,2024

Lifestyle changes prevent cognitive decline even in genetically susceptible individuals

by University of Eastern FinlandEnhanced lifestyle counselling prevents cognitive decline even in people who are carriers of the APOE4 gene, a common risk factor of Alzheimer's disease, accor

Updated on: March 07,2024

Lifestyle changes prevent cognitive decline even in genetically susceptible individuals

by University of Eastern FinlandEnhanced lifestyle counselling prevents cognitive decline even in people who are carriers of the APOE4 gene, a common risk factor of Alzheimer's disease, accor

Updated on:March 07,2024

3D brain mapping opens a window to the aging brain

FEBRUARY 9, 2024by Bill Snyder,Vanderbilt UniversityIllustration of the triple-wise correlation network model. Credit:Science Advances(2024). DOI: 10.1126/sciadv.adi0616By mapping br

Updated on: March 13,2024

3D brain mapping opens a window to the aging brain

FEBRUARY 9, 2024by Bill Snyder,Vanderbilt UniversityIllustration of the triple-wise correlation network model. Credit:Science Advances(2024). DOI: 10.1126/sciadv.adi0616By mapping br

Updated on:March 13,2024

Protein misfolding as a risk marker for Alzheimer's disease

by German Cancer Research CenterCredit: CC0 Public DomainIn symptom-free individuals, the detection of misfolded amyloid-β protein in the blood indicates a considerably higher risk of Alzheimer&#

Updated on: May 20,2024

Protein misfolding as a risk marker for Alzheimer's disease

by German Cancer Research CenterCredit: CC0 Public DomainIn symptom-free individuals, the detection of misfolded amyloid-β protein in the blood indicates a considerably higher risk of Alzheimer&#

Updated on:May 20,2024

Computer simulations explore how Alzheimer's disease starts

by Rice UniversityA team of Rice University researchers built computer simulations of amyloid beta proteins to see what their energy landscapes reveal about the formation of plaques in patients w

Updated on: June 18,2024

Computer simulations explore how Alzheimer's disease starts

by Rice UniversityA team of Rice University researchers built computer simulations of amyloid beta proteins to see what their energy landscapes reveal about the formation of plaques in patients w

Updated on:June 18,2024

First 'gene silencing' drug for Alzheimer's disease shows promise

by University College LondonEffect of MAPTRxon CSF concentrations of p-tau protein and tau/Aβ42. a, The mean percentage change from baseline in p-tau over time according to dose group. b, T

Updated on: March 30,2024

First 'gene silencing' drug for Alzheimer's disease shows promise

by University College LondonEffect of MAPTRxon CSF concentrations of p-tau protein and tau/Aβ42. a, The mean percentage change from baseline in p-tau over time according to dose group. b, T

Updated on:March 30,2024

Clinical trial results for lecanemab are a significant step for Alzheimer's, but not a historic breakthrough

by University of New South WalesAmyloid plaques and neurofibrillary tangles occur in the brains of patients with Alzheimer's disease. Credit: Ian JosonPartner companies Eisai and Biogen recen

Updated on: March 30,2024

Clinical trial results for lecanemab are a significant step for Alzheimer's, but not a historic breakthrough

by University of New South WalesAmyloid plaques and neurofibrillary tangles occur in the brains of patients with Alzheimer's disease. Credit: Ian JosonPartner companies Eisai and Biogen recen

Updated on:March 30,2024